Tag: Alectinib

Tag Visualization: Top 50 related tags by occurrence

Recent Related Articles to Alectinib

Pfizer Gets EC OK for Lorviqua as First-Line Treatment for ALK-Positive Advanced Lung ...

Added to Collection on: 2022-01-28 18:08:35

Tags for this article:

Chemical compounds
Organic compounds
Aromatic compounds
Breakthrough therapy
Piperidines
Lung cancer
Tyrosine kinase receptors
Anaplastic lymphoma kinase
Ceritinib
Crizotinib
ALK inhibitor
Alectinib

Click the tags to see associated articles and topics

View Article Details
Pfizer (PFE) Lorviqua Gets EU Nod for First-Line Lung Cancer - Entrepreneur

Added to Collection on: 2022-01-31 18:16:09

Tags for this article:

Chemical compounds
Organic compounds
Chemistry
Breakthrough therapy
Piperidines
Lung cancer
Tyrosine kinase receptors
Ceritinib
ALK inhibitor
Anaplastic lymphoma kinase
Crizotinib
Alectinib

Click the tags to see associated articles and topics

View Article Details
Alectinib Market is Booming Worldwide with Roche, Everest Pharmaceuticals - Talking Democrat

Added to Collection on: 2022-02-15 09:04:04

Tags for this article:

Business process
Articles
Business
Economy
Alectinib
Market analysis
Market segmentation
Market research
Marketing strategy
Market
Competition
Financial market

Click the tags to see associated articles and topics

View Article Details
Research Report on China's Alectinib Markets, 2016-2020 & 2021-2025 - Headlines of Today

Added to Collection on: 2022-03-12 05:14:17

Tags for this article:

Chemical compounds
Organic compounds
Functional groups
Breakthrough therapy
Alectinib
Ketones
Morpholines
Nitriles
Piperidines
Brain metastasis
Roche
Anaplastic lymphoma kinase
China

Click the tags to see associated articles and topics

View Article Details
Alectinib Drugs Sales Market Size 2022 Analysis by 2029 | Key Players – Roche

Added to Collection on: 2022-05-12 20:15:44

Tags for this article:

Business process
Business
Articles
Enterprise modelling
Market analysis
Market research
Market segmentation
Alectinib
Market share
Marketing
Market

Click the tags to see associated articles and topics

View Article Details
A novel IGR-ALK fusion in a patient with lung adenocarcinoma | OTT - Dove Medical Press

Added to Collection on: 2024-03-26 16:24:41

Tags for this article:

Lung cancer
CYP3A4 inhibitors
Pyrazoles
Piperidines
Orphan drugs
ALK inhibitor
Anaplastic lymphoma kinase
Crizotinib
Ceritinib
Adenocarcinoma of the lung
Non-small-cell lung cancer
Alectinib

Click the tags to see associated articles and topics

View Article Details
Refining Adjuvant Immunotherapy Use is a Crucial Focus in Early-Stage NSCLC - OncLive

Added to Collection on: 2024-08-03 07:17:00

Tags for this article:

Orphan drugs
Antineoplastic drugs
Lung cancer
Cancer treatments
Tyrosine kinase receptors
Adjuvant therapy
Non-small-cell lung cancer
Alectinib
Pembrolizumab
Nivolumab
Anaplastic lymphoma kinase
Epidermal growth factor receptor

Click the tags to see associated articles and topics

View Article Details
Genprex Signs Exclusive License to Additional Gene Therapy Technologies with the ... - Placera

Added to Collection on: 2024-11-20 14:39:25

Tags for this article:

Lung cancer
ALK inhibitor
Anaplastic lymphoma kinase
Non-small-cell lung cancer
Alectinib
Small-cell carcinoma
Cancer research
ALK positive lung cancer
Treatment of lung cancer

Click the tags to see associated articles and topics

View Article Details
Genprex Signs Exclusive License to Additional Gene Therapy Technologies with ... - PR Newswire

Added to Collection on: 2024-11-20 14:34:06

Tags for this article:

Lung cancer
ALK inhibitor
Anaplastic lymphoma kinase
Non-small-cell lung cancer
Alectinib
Small-cell carcinoma
ALK positive lung cancer
Treatment of lung cancer

Click the tags to see associated articles and topics

View Article Details
Strategic and Safe Lorlatinib Use Is Key to Optimal ALK+ NSCLC Management - OncLive

Added to Collection on: 2025-02-21 21:19:48

Tags for this article:

Pyrazoles
Orphan drugs
Lung cancer
Tyrosine kinase receptors
Antineoplastic drugs
Lorlatinib
ALK inhibitor
Crizotinib
Anaplastic lymphoma kinase
Non-small-cell lung cancer
ALK positive lung cancer
ROS1
Alectinib

Click the tags to see associated articles and topics

View Article Details